May 24, 2022
During the pandemic, the intellectual property (IP) system spurred the creation of numerous partnerships, leading to the development of safe and effective vaccines and the production of billions of doses.
Recently, some governments have called for the elimination or temporary suspension of intellectual property rights to allow global and affordable access to vaccines and treatments. However, this decision would not only not increase production but would be highly counterproductive:
- it would destroy the international production collaborations and partnerships that have proved indispensable;
- it would undermine the incentive to invest in research and development (R&D) of new technologies and therapies.